[go: up one dir, main page]

IL147891A0 - Topical use of anti-muscarnic agents - Google Patents

Topical use of anti-muscarnic agents

Info

Publication number
IL147891A0
IL147891A0 IL14789100A IL14789100A IL147891A0 IL 147891 A0 IL147891 A0 IL 147891A0 IL 14789100 A IL14789100 A IL 14789100A IL 14789100 A IL14789100 A IL 14789100A IL 147891 A0 IL147891 A0 IL 147891A0
Authority
IL
Israel
Prior art keywords
muscarnic
agents
topical use
topical
muscarnic agents
Prior art date
Application number
IL14789100A
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of IL147891A0 publication Critical patent/IL147891A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14789100A 1999-08-09 2000-08-07 Topical use of anti-muscarnic agents IL147891A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9918760.1A GB9918760D0 (en) 1999-08-09 1999-08-09 Topical treatment
PCT/GB2000/003032 WO2001010427A2 (en) 1999-08-09 2000-08-07 Use of anti-muscarinic agents for treating skin disorders

Publications (1)

Publication Number Publication Date
IL147891A0 true IL147891A0 (en) 2002-08-14

Family

ID=10858850

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14789100A IL147891A0 (en) 1999-08-09 2000-08-07 Topical use of anti-muscarnic agents

Country Status (8)

Country Link
EP (1) EP1202723A2 (en)
JP (1) JP2003506405A (en)
AU (1) AU6306400A (en)
CA (1) CA2378445A1 (en)
GB (1) GB9918760D0 (en)
IL (1) IL147891A0 (en)
WO (1) WO2001010427A2 (en)
ZA (1) ZA200200795B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1302458A4 (en) * 2000-07-11 2005-10-19 Banyu Pharma Co Ltd ESTER DERIVATIVES
DE10111843A1 (en) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Compounds for the treatment of inflammatory diseases
DE102004016179A1 (en) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Compounds for the treatment of proliferative processes
WO2006054312A1 (en) * 2004-11-16 2006-05-26 Munisekhar Medasani Ammonium compounds for treating psoriasis and eczema
JP5107933B2 (en) * 2005-12-21 2012-12-26 メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト Anti-cholinergic drugs, β2-adrenergic receptor agonists, anti-leukotrienes (antagonists of leukotriene receptors), glucocorticoids and / or PDE4 inhibitors for use in the treatment of inflammatory diseases
GB0611240D0 (en) * 2006-06-07 2006-07-19 Daniolabs Ltd The treatment of increased sebum production
WO2009068876A1 (en) * 2007-11-30 2009-06-04 Summit Corporation Plc Compositions for the treatment of skin disorders
WO2009150408A2 (en) * 2008-06-13 2009-12-17 Summit Corporation Plc Topical antimuscarinic formulations
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
ES2699257T3 (en) 2013-02-28 2019-02-08 Dermira Inc Salts of glycopyrrolate
MX368097B (en) 2015-04-28 2019-09-19 Unilever Nv N-aralkylcarbonyldiamine compounds and personal care compositions comprising the same.
WO2016173817A1 (en) 2015-04-28 2016-11-03 Unilever Plc N-aralkylcarbonyl-piperazine and -homopiperazine compounds and personal care compositions comprising the same
CN112730821B (en) * 2019-10-14 2024-04-09 泰州医药城国科化物生物医药科技有限公司 Method for analyzing long-acting property of receptor antagonist
CN110898227A (en) * 2019-11-04 2020-03-24 上海交通大学医学院附属瑞金医院卢湾分院 Combined medicine for treating psoriasis and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19626373A1 (en) * 1996-07-02 1998-01-08 Boehringer Ingelheim Kg Novel use of active ingredients that affect the function of non-neuronal acetylcholine
US6011022A (en) * 1998-03-03 2000-01-04 El Khoury; George F. Topical application of muscarinic analgesic drugs such as neostigmine

Also Published As

Publication number Publication date
JP2003506405A (en) 2003-02-18
WO2001010427A3 (en) 2001-09-20
GB9918760D0 (en) 1999-10-13
ZA200200795B (en) 2003-03-26
AU6306400A (en) 2001-03-05
CA2378445A1 (en) 2001-02-15
WO2001010427A2 (en) 2001-02-15
EP1202723A2 (en) 2002-05-08

Similar Documents

Publication Publication Date Title
IL147296A0 (en) Imidazoimidazoles and triazoles as anti-inflammatory agents
GB9911863D0 (en) Therapeutic agents
GB9905010D0 (en) Therapeutic agents
IL150030A0 (en) Therapeutic agents
GB9904786D0 (en) Therapeutic agents
PL355101A1 (en) Use of h1
GB9929685D0 (en) Therapeutic agents
GB9929687D0 (en) Therapeutic agents
IL147891A0 (en) Topical use of anti-muscarnic agents
GB9921351D0 (en) Therapeutic agents
GB9911881D0 (en) Therapeutic agents
GB9903476D0 (en) Therapeutic agents
GB9929569D0 (en) Therapeutic agents
GB9914745D0 (en) Therapeutic agents
GB9914744D0 (en) Therapeutic agents
GB9903119D0 (en) Therapeutic agents
IL147078A0 (en) Therapeutic agents
PL350963A1 (en) Use of arylalkanoylpyridazines
GB9902881D0 (en) Therapeutic agents
GB9914743D0 (en) Therapeutic agents
GB9901444D0 (en) Anti-inflammatory agents
GB9911238D0 (en) Therapeutic use
GB9915616D0 (en) Therapeutic agents
EP1121118A4 (en) Formamides as therapeutic agents
GB9906124D0 (en) Therapeutic agent